Immune Signature

Relationship between immune gene signatures and clinical response to PD-1 blockade with pembrolizumab (MK-3475) in patients with advanced solid tumors
Mark Ayers, Jared Lunceford, Michael Nebozhyn, Erin Murphy, Andrey Loboda, Andrew Albright, Jonathan Cheng, S Peter Kang, Scot Ebbinghaus, Jennifer Yearley, Veena Shankaran, Tanguy Seiwert, Antoni Ribas, Terri McClanahan

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P80; DOI: 10.1186/2051-1426-3-S2-P80
Linking tumor with systemic environment in the search for novel biomarkers in breast cancer
Sotirios P Fortis, Louisa G Mahaira, Michael Sofopoulos, Nectaria Sotiriadou, Christoforos Haritos, John F Voutsas, Nikolaos Anastasopoulos, Niki Arnogiannaki, Christopher Shipp, Graham Pawelec, Sonia A Perez, Constantin Baxevanis

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P87; DOI: 10.1186/2051-1426-3-S2-P87
TLR2/6 agonists and IFN-gamma treatment induces favorable immune cell recruiting signatures from melanoma associated with STAT1 and IL-32 signaling
Ileana S Mauldin, Craig L Slingluff, Ena Wang

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P225; DOI: 10.1186/2051-1426-2-S3-P225

Main menu